Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "bundlepackageleaflet-en-c90b79fb8cf9d2067c35819ca84918df",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"
]
},
"language" : "en",
"identifier" : {
"system" : "http://ema.europa.eu/identifier",
"value" : "None"
},
"type" : "document",
"timestamp" : "2023-06-27T10:09:22Z",
"entry" : [
{
"fullUrl" : "Composition/composition-en-c90b79fb8cf9d2067c35819ca84918df",
"resource" : {
"resourceType" : "Composition",
"id" : "composition-en-c90b79fb8cf9d2067c35819ca84918df",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><a name=\"Composition_composition-en-c90b79fb8cf9d2067c35819ca84918df\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Composition composition-en-c90b79fb8cf9d2067c35819ca84918df</b></p><a name=\"composition-en-c90b79fb8cf9d2067c35819ca84918df\"> </a><a name=\"hccomposition-en-c90b79fb8cf9d2067c35819ca84918df\"> </a><a name=\"composition-en-c90b79fb8cf9d2067c35819ca84918df-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html\">Composition (ePI)</a></p></div><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/EU/1/13/856/001</p><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi/ 100000155538}\">Package Leaflet</span></p><p><b>category</b>: <span title=\"Codes:{http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs R}\">Raw</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: <a href=\"Organization-mah-ema.html\">Organization ACME industry</a></p><p><b>title</b>: TEST PURPOSES ONLY - lonquex</p><h3>Attesters</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/composition-attestation-mode official}\">Official</span></td><td>2022-02-16 13:28:17+0000</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/identifier",
"value" : "EU/1/13/856/001"
}
],
"status" : "final",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "Package Leaflet"
},
"category" : [
{
"coding" : [
{
"system" : "http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs",
"code" : "R",
"display" : "Raw"
}
]
}
],
"subject" : [
{
"reference" : "MedicinalProductDefinition/mpc90b79fb8cf9d2067c35819ca84918df"
}
],
"date" : "2022-02-16T13:28:17Z",
"author" : [
{
🔗 "reference" : "Organization/mah-ema"
}
],
"title" : "TEST PURPOSES ONLY - lonquex",
"attester" : [
{
"mode" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/composition-attestation-mode",
"code" : "official"
}
]
},
"time" : "2022-02-16T13:28:17Z"
}
],
"section" : [
{
"title" : "B. Package Leaflet",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "B. Package Leaflet"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
},
"emptyReason" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason",
"code" : "unavailable"
}
]
},
"section" : [
{
"title" : "Package leaflet: Information for the user",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "Package leaflet: Information for the user"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
}
},
{
"title" : "What is in this leaflet",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "What is in this leaflet"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What is in this leaflet</p><ol type=\"1\"><li>What Lonquex is and what it is used for</li><li>What you need to know before you use Lonquex</li><li>How to use Lonquex</li><li>Possible side effects</li><li>How to store Lonquex</li><li>Contents of the pack and other information</li></ol></div>"
}
},
{
"title" : "1. What lonquex is and what it is used for",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "1. What lonquex is and what it is used for"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What Lonquex is Lonquex contains the active substance lipegfilgrastim. Lipegfilgrastim is a long-acting modified protein produced by biotechnology in bacteria called Escherichia coli. It belongs to a group of proteins called cytokines and is similar to a natural protein (granulocyte-colony stimulating factor [G-CSF]) produced by your own body.</p><p>What Lonquex is used for Lonquex is used in adults and in children aged 2 years and older.</p><p>Your doctor has prescribed Lonquex for you or for your child in order to reduce the duration of a condition called neutropenia (low white blood cell count) and the occurrence of febrile neutropenia (low white blood cell count with a fever). These can be caused by the use of cytotoxic chemotherapy (medicines that destroy rapidly-growing cells).</p><p>How Lonquex works Lipegfilgrastim stimulates the bone marrow (the tissue where new blood cells are made) to produce more white blood cells. White blood cells are important as they help your body fight infection. These cells are very sensitive to the effects of chemotherapy which can cause the number of these cells in your body to decrease. If white blood cells fall to a low level, there may not be enough left in the body to fight bacteria and you may have an increased risk of infection.</p></div>"
}
},
{
"title" : "2. What you need to know before you take lonquex",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "2. What you need to know before you take lonquex"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Do not use Lonquex</p><ul><li>if you or your child are allergic to lipegfilgrastim or any of the other ingredients of this medicine (listed in section 6).</li></ul><p>Warnings and precautions Talk to your doctor, pharmacist or nurse before using Lonquex:</p><ul><li>if you or your child get left upper abdominal pain or pain at the tip of your shoulder. It could be a consequence of a spleen disorder (see section 4 Possible side effects ).</li><li>if you or your child have a cough, fever and difficulty breathing. It could be a consequence of a pulmonary disorder (see section 4 Possible side effects ).</li><li>if you or your child have sickle cell anaemia, which is an inherited disease characterised by sickle-shaped red blood cells.</li><li>if you or your child have previously experienced allergic reactions to other medicines like this one (e.g. filgrastim, lenograstim or pegfilgrastim of the group of G-CSFs). There could be a risk of reacting to Lonquex too.</li></ul><p>Your doctor will carry out regular blood tests in order to monitor various blood components and their levels. Your doctor will also check your or your child`s urine regularly as other medicines similar to this one (e.g. other granulocyte colony stimulating factors such as filgrastim, lenograstim or pegfilgrastim) can possibly harm the tiny filters inside your kidneys (glomerulonephritis; see section 4. Possible side effects ).</p><p>Tell your doctor if you or your child are being treated for breast or lung cancer in combination with chemotherapy and/or radiation therapy and experience symptoms such as tiredness, fever, and easy bruising or bleeding. These symptoms could be a consequence of a precancerous blood condition called myelodysplastic syndrome (MDS) or of a blood cancer called acute myeloid leukaemia (AML) which have been associated with another medicine like this one (pegfilgrastim of the group of G-CSFs).</p><p>Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported rarely with other medicines like this one (e.g. filgrastim, lenograstim or pegfilgrastim of the group of G-CSFs). The symptoms can include fever, abdominal pain, malaise, back pain and increased inflammatory markers. Tell your doctor if you experience these symptoms.</p><p>Children and adolescents Lonquex is not recommended for children younger than 2 years of age.</p><p>Other medicines and Lonquex Tell your doctor or pharmacist if you or your child are using, have recently used or might use any other medicines.</p><p>Pregnancy and breast-feeding Lonquex has not been tested in pregnant women. It is important to tell your doctor if you are pregnant, think you may be pregnant or are planning to have a baby, as the doctor may decide that you should not use this medicine.</p><p>It is unknown whether the active substance in this medicine passes into the breast milk. You should therefore interrupt breast-feeding during treatment.</p><p>Driving and using machines Lonquex has no or negligible influence on your ability to drive and use machines.</p><p>Lonquex contains sorbitol This medicine contains 30 mg sorbitol in each pre-filled syringe.</p><p>Lonquex contains sodium This medicine contains less than 1 mmol sodium (23 mg) per pre-filled syringe, that is to say essentially sodium-free .</p></div>"
}
},
{
"title" : "3. How to take lonquex",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "3. How to take lonquex"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>What the recommended dose is The recommended dose is one pre-filled syringe (6 mg lipegfilgrastim) once per chemotherapy cycle.</p><p>The pre-filled syringe is only suitable for adults or for children weighing 45 kg and more.</p><p>Lonquex is also available in a vial presentation for children weighing less than 45 kg. The recommended dose will be based on their body weight and the adequate dose will be given by a doctor or a nurse.</p><p>When to use Lonquex The Lonquex dose will normally be injected approximately 24 hours after the last dose of chemotherapy at the end of each chemotherapy cycle.</p><p>How are the injections given? This medicine is given as an injection using a pre-filled syringe. The injection is given into the tissue just under the skin (subcutaneous injection).</p><p>Your doctor may suggest that you learn how to inject yourself with this medicine or how to give the injection to your child. Your doctor or nurse will give you instructions on how to do this. Do not attempt to give Lonquex to yourself or to your child without this training. Information required for using the pre-filled syringe can be found under Information for injecting yourself or your child . Proper treatment of your or of your child s disease, however, requires close and constant co-operation with your doctor.</p><p>Information for injecting yourself or your child</p><p>This section contains information on how to give yourself or your child an injection of Lonquex under the skin. It is important that you do not try to give yourself or your child the injection unless you have received special training from your doctor or nurse. If you are not sure about giving yourself or your child the injection or you have any questions, please ask your doctor or nurse for help.</p><p>How Lonquex is used You will need to give yourself or your child the injection into the tissue just under the skin. This is known as a subcutaneous injection.</p><p>Equipment that you need To give yourself or your child an injection into the tissue under the skin you will need:</p><ul><li>a pre-filled syringe of Lonquex,</li><li>an alcohol wipe,</li><li>a piece of gauze bandage or a sterile gauze swab,</li><li>a puncture-proof container (plastic container provided by the hospital or pharmacy) so you can dispose of used syringes safely.</li></ul><p>What you should do before the injection</p><ol type=\"1\"><li>Take the medicine out of the refrigerator.</li><li>Open the blister and take the pre-filled syringe out of the blister (see picture 1). Do not pick up the pre-filled syringe by the plunger or needle cover.</li><li>Check the expiry date on the pre-filled syringe label (EXP). Do not use it if the date has passed the last day of the month shown.</li><li>Check the appearance of Lonquex. It must be a clear and colourless liquid. If there are particles in it or if it is cloudy, you must not use it.</li><li>Do not shake Lonquex vigorously as this may affect its activity.</li><li>For a more comfortable injection:</li></ol><ul><li>let the pre-filled syringe stand for 30 minutes to reach room temperature (not above 25 C) or</li><li>hold the pre-filled syringe gently in your hand for a few minutes. Do not warm Lonquex in any other way (for example, do not warm it in a microwave or in hot water).</li></ul><ol start=\"7\" type=\"1\"><li>Do not remove the needle cover from the syringe until you are ready to inject.</li><li>Find a comfortable, well-lit place. Put everything you need within easy reach (the Lonquex pre-filled syringe, an alcohol wipe, a piece of gauze bandage or a sterile gauze swab and the puncture-proof container).</li><li>Wash your hands thoroughly.</li></ol><p>1</p><p>Where the injection should be given The most suitable places for the injection are:</p><ul><li>the top of the thighs,</li><li>the abdomen (see grey areas in picture 2) avoiding the skin directly surrounding the navel.</li></ul><p>2</p><p>If someone else is injecting you or if you are injecting your child, the following places can also be used:</p><ul><li>the back and side of the upper arms (see grey areas in pictures 3 and 4).</li></ul><p>3 4</p><p>How to prepare for the injection Before you give yourself or your child a Lonquex injection, you must do the following:</p><ol type=\"1\"><li>Disinfect the injection site on the skin by using an alcohol wipe.</li><li>Hold the syringe and gently remove the cover from the needle without twisting. Pull straight as shown in pictures 5 and 6. Do not touch the needle or push the plunger.</li></ol><p>5 6</p><ol start=\"3\" type=\"1\"><li>You may notice small air bubbles in the pre-filled syringe. If there are air bubbles present, hold the syringe with the needle pointing upwards (see picture 7), gently tap the syringe with your fingers until the air bubbles rise to the top of the syringe. With the syringe pointing upwards, expel all air from the syringe by pushing the plunger slowly upwards.</li></ol><p>7</p><ol start=\"4\" type=\"1\"><li>You can now use the pre-filled syringe.</li></ol><p>How you should inject yourself or your child</p><ol type=\"1\"><li>Pinch the disinfected skin between your thumb and forefinger, without squeezing it (see picture 8).</li><li>Put the needle fully into the skin as shown by your doctor or nurse. The angle between the syringe and skin should not be too narrow (at least 45 , see picture 9).</li><li>Inject the liquid into the tissue slowly and evenly, always keeping the skin pinched.</li><li>After injecting the liquid, remove the needle and let go of the skin.</li><li>Press the injection site with a piece of gauze bandage or a sterile gauze swab for several seconds.</li><li>Only use each syringe for one injection. Do not use any Lonquex that is left in the syringe.</li></ol><p>8 9</p><p>Remember If you have any problems, please ask your doctor or nurse for help and advice.</p><p>Disposing of used syringes</p><ul><li>Do not put the cover back on used needles.</li><li>Put used syringes into the puncture-proof container and keep this container out of the sight and reach of children.</li><li>Dispose of the full puncture-proof container as instructed by your doctor, pharmacist or nurse.</li><li>Never put the syringes that you have used into your normal household rubbish bin.</li></ul><p>Information for injecting yourself or your child</p><p>This section contains information on how to give yourself or your child an injection of Lonquex under the skin. It is important that you do not try to give yourself or your child the injection unless you have received special training from your doctor or nurse. If you are not sure about giving yourself the injection or you have any questions, please ask your doctor or nurse for help.</p><p>How Lonquex is used You will need to give yourself or your child the injection into the tissue just under the skin. This is known as a subcutaneous injection.</p><p>Equipment that you need To give yourself or your child an injection into the tissue under the skin you will need:</p><ul><li>a pre-filled syringe of Lonquex,</li><li>an alcohol wipe,</li><li>a piece of gauze bandage or a sterile gauze swab.</li></ul><p>What you should do before the injection</p><ol type=\"1\"><li>Take the medicine out of the refrigerator.</li><li>Open the blister and take the pre-filled syringe out of the blister (see picture 1). Do not pick up the pre-filled syringe by the plunger or needle cover. This could damage the safety device.</li><li>Check the expiry date on the pre-filled syringe label (EXP). Do not use it if the date has passed the last day of the month shown.</li><li>Check the appearance of Lonquex. It must be a clear and colourless liquid. If there are particles in it or if it is cloudy, you must not use it.</li><li>Do not shake Lonquex vigorously as this may affect its activity.</li><li>For a more comfortable injection:</li></ol><ul><li><p>let the pre-filled syringe stand for 30 minutes to reach room temperature (not above<br/>25 C) or</p></li><li><p>hold the pre-filled syringe gently in your hand for a few minutes.</p></li></ul><p>Do not warm Lonquex in any other way (for example, do not warm it in a microwave or in hot water). 7. Do not remove the needle cover from the syringe until you are ready to inject. 8. Find a comfortable, well-lit place. Put everything you need within easy reach (the Lonquex pre-filled syringe, an alcohol wipe and a piece of gauze bandage or a sterile gauze swab). 9. Wash your hands thoroughly.</p><p>1</p><p>Where the injection should be given The most suitable places for the injection are:</p><ul><li>the top of the thighs,</li><li>the abdomen (see grey areas in picture 2) avoiding the skin directly surrounding the navel.</li></ul><p>2</p><p>If someone else is injecting you or if you are injecting your child, the following places can also be used:</p><ul><li>the back and side of the upper arms (see grey areas in pictures 3 and 4).</li></ul><p>3 4</p><p>How to prepare for the injection Before you give yourself or your child a Lonquex injection, you must do the following:</p><ol type=\"1\"><li>Disinfect the injection site on the skin by using an alcohol wipe.</li><li>Hold the syringe and gently remove the cover from the needle without twisting. Pull straight as shown in pictures 5 and 6. Do not touch the needle or push the plunger.</li></ol><p>5 6</p><ol start=\"3\" type=\"1\"><li>You may notice small air bubbles in the pre-filled syringe. If there are air bubbles present, hold the syringe with the needle pointing upwards (see picture 7), gently tap the syringe with your fingers until the air bubbles rise to the top of the syringe. With the syringe pointing upwards, expel all air from the syringe by pushing the plunger slowly upwards.</li></ol><p>7</p><ol start=\"4\" type=\"1\"><li>You can now use the pre-filled syringe.</li></ol><p>How you should inject yourself or your child</p><ol type=\"1\"><li>Pinch the disinfected skin between your thumb and forefinger, without squeezing it (see picture 8).</li><li>Put the needle fully into the skin as shown by your doctor or nurse. The angle between the syringe and skin should not be too narrow (at least 45 , see picture 9).</li><li>Inject the liquid into the tissue slowly and evenly, always keeping the skin pinched (see picture 10).</li><li>Push the plunger as far as it will go to inject all the liquid. While the plunger is still pressed all the way down, remove the needle from the skin (see picture 11). Then release the plunger. The safety device will be activated immediately. The entire needle and syringe will be drawn back automatically and covered so that you cannot prick yourself (see picture 12).</li><li>Press the injection site with a piece of gauze bandage or a sterile gauze swab for several seconds.</li><li>Each pre-filled syringe is for single use only.</li></ol><p>8 9 Remember If you have any problems, please ask your doctor or nurse for help and advice.</p><p>If you use more Lonquex than you should If you use more Lonquex than you should, talk to your doctor.</p><p>If you forget to use Lonquex If you have missed an injection, contact your doctor to discuss when you should inject the next dose.</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p></div>"
}
},
{
"title" : "4. Possible side effects",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "4. Possible side effects"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Most serious side effects</p><ul><li>Allergic reactions such as skin rash, raised itchy areas of skin and serious allergic reactions with weakness, drop in blood pressure, difficulty breathing and swelling of the face have been reported uncommonly (may affect up to 1 in 100 people). If you think you are having this type of reaction, you must stop your Lonquex injection and get medical help immediately.</li><li>Increased spleen size has been reported uncommonly and cases of splenic ruptures have been reported with other medicines similar to Lonquex. Some cases of splenic rupture were fatal. It is important to contact your doctor immediately if you experience pain in the upper left side of the abdomen or left shoulder pain since this may relate to a problem with your spleen.</li><li>Cough, fever and difficult or painful breathing can be signs of uncommon serious pulmonary side effects, such as pneumonia and acute respiratory distress syndrome, which may be fatal. If you have a fever or any of these symptoms, it is important to contact your doctor immediately.</li><li>It is important to contact your doctor immediately if you have any of the following symptoms: swelling or puffiness, which may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness. These symptoms generally develop in a rapid fashion. These could be symptoms of a condition reported with frequency not known (cannot be estimated from the available data), called capillary leak syndrome , which causes blood to leak from the small blood vessels into your body and needs urgent medical attention.</li></ul><p>Other side effects</p><p>Very common (may affect more than 1 in 10 people)</p><ul><li>Musculoskeletal pains such as bone pain and pain in the joints, muscles, limbs, chest, neck or back. Tell your doctor if you experience severe musculoskeletal pain.</li><li>Nausea.</li></ul><p>Common (may affect up to 1 in 10 people)</p><ul><li>Reduction in blood platelets, which increases risk of bleeding or bruising.</li><li>Headache.</li><li>Skin reactions, such as redness or rash.</li><li>Low blood levels of potassium, which can cause muscle weakness, twitching or abnormal heart rhythm.</li><li>Chest pain.</li><li>Coughing up blood.</li></ul><p>Uncommon (may affect up to 1 in 100 people)</p><ul><li>Rise in white blood cells.</li><li>Local reactions at the injection site, such as pain or hardening.</li><li>Some changes may occur in your blood, but these will be detected by routine blood tests.</li><li>Bleeding from the lung.</li></ul><p>Not known (frequency cannot be estimated from the available data):</p><ul><li>Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body), see section 2. Side effects that have been seen with similar medicines, but not yet with Lonquex</li><li>Sickle cell crises in patients with sickle cell anaemia.</li><li>Plum-coloured raised painful sores on the limbs and sometimes the face and neck with fever (Sweet s syndrome).</li><li>Inflammation of the blood vessels in the skin.</li><li>Damage to the tiny filters inside your kidneys (glomerulonephritis; see section 2 under Warnings and precautions ).</li></ul><p>Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.</p></div>"
}
},
{
"title" : "5. How to store lonquex",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "5. How to store lonquex"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the outer carton and on the label of the pre-filled syringe after EXP. The expiry date refers to the last day of that month.</p><p>Store in a refrigerator (2 C 8 C).</p><p>Do not freeze.</p><p>Keep the pre-filled syringe in the outer carton, in order to protect from light.</p><p>Lonquex may be removed from the refrigerator and stored below 25 C for a maximum single period of up to 7 days. Once removed from the refrigerator, the medicine must be used within this period or disposed of.</p><p>Do not use this medicine if you notice that it is cloudy or there are particles in it.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p></div>"
}
},
{
"title" : "6. Contents of the pack and other information",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi/",
"code" : "100000155538"
}
],
"text" : "6. Contents of the pack and other information"
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What Lonquex contains</p><ul><li>The active substance is lipegfilgrastim. Each pre-filled syringe contains 6 mg lipegfilgrastim. Each ml solution contains 10 mg lipegfilgrastim.</li><li>The other ingredients (excipients) are glacial acetic acid, sodium hydroxide (see section 2 Lonquex contains sodium ), sorbitol (E420) (see section 2 Lonquex contains sorbitol ), polysorbate 20 and water for injections.</li></ul><p>What Lonquex looks like and contents of the pack Lonquex is a solution for injection (injection) in pre-filled syringe with a fixed injection needle in a blister. Lonquex is a clear and colourless solution. If there are particles in it or if it is cloudy, you must not use it.</p><p>Each pre-filled syringe contains 0.6 ml solution.</p><p>Lonquex is available in packs containing 1 and 4 pre-filled syringes with safety device or 1 pre-filled syringe without safety device.</p><p>Not all pack sizes may be marketed.</p><p>Marketing Authorisation Holder Teva B.V. Swensweg 5 2031 GA Haarlem Netherlands</p><p>Manufacturer Teva Biotech GmbH Dornierstra e 89079 Ulm Germany</p><p>Merckle GmbH, Graf-Arco-Stra e 3 89079 Ulm Germany</p><p>For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</p><p>Belgi /Belgique/Belgien Teva Pharma Belgium N.V./S.A./AG T l/Tel: +32 38207Lietuva UAB Teva Baltics Tel: +370 52660</p><p>Te : +359 24899Luxembourg/Luxemburg Teva Pharma Belgium N.V./S.A./AG Belgique/Belgien T l/Tel: +32 38207 esk republika Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007Magyarorsz g Teva Gy gyszergy r Zrt. Tel: +36 12886Danmark Teva Denmark A/S Tlf: +45 44985Malta Teva Pharmaceuticals Ireland L-Irlanda Tel: +44 2075407Deutschland TEVA GmbH Tel: +49 73140Nederland Teva Nederland B.V. Tel: +31 8000228Eesti UAB Teva Baltics Eesti filiaal Tel: +372 6610Norge Teva Norway AS Tlf: +47 66775<br/>TEVA HELLAS . . : +30 2118805 sterreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970Espa a Teva Pharma, S.L.U. Tel: +34 913873Polska Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459France Teva Sant<br/>T l: +33 155917Portugal Teva Pharma - Produtos Farmac uticos, Lda. Tel: +351 214767Hrvatska Pliva Hrvatska d.o.o. Tel: +385 13720Rom nia Teva Pharmaceuticals S.R.L. Tel: +40 212306Ireland Teva Pharmaceuticals Ireland Tel: +44 2075407Slovenija Pliva Ljubljana d.o.o. Tel: +386 15890 sland Alvogen ehf. S mi: +354 5222Slovensk republika TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267Italia Suomi/Finland Teva Italia S.r.l. Tel: +39 028917Teva Finland Oy Puh/Tel: +358 201805<br/>TEVA HELLAS . .</p><p>: +30 2118805Sverige Teva Sweden AB Tel: +46 42121Latvija UAB Teva Baltics fili le Latvij<br/>Tel: +371 67323United Kingdom (Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407This leaflet was last revised in {month YYYY}.</p><p>Detailed information on this medicine is available on the European Medicines Agency web site:</p></div>"
}
}
]
}
]
}
},
{
"fullUrl" : "MedicinalProductDefinition/mpc90b79fb8cf9d2067c35819ca84918df",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "mpc90b79fb8cf9d2067c35819ca84918df",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_mpc90b79fb8cf9d2067c35819ca84918df\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition mpc90b79fb8cf9d2067c35819ca84918df</b></p><a name=\"mpc90b79fb8cf9d2067c35819ca84918df\"> </a><a name=\"hcmpc90b79fb8cf9d2067c35819ca84918df\"> </a><a name=\"mpc90b79fb8cf9d2067c35819ca84918df-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/EU/1/13/856/001</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-type MedicinalProduct}\">Medicinal Product</span></p><p><b>domain</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-domain Human}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">active</span></p><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000072084}\">Medicinal product subject to medical prescription</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Lonquex 6 mg solution for injection in pre-filled syringe</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000001}\">Full name</span></p><blockquote><p><b>part</b></p><p><b>part</b>: nan</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000002}\">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: nan</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000003}\">Scientific name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: nan</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: nan</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 EU}\">EU</span></td><td><span title=\"Codes:{urn:iso:std:iso:3166 EU}\">EU</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 en}\">en</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/identifier",
"value" : "EU/1/13/856/001"
}
],
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-type",
"code" : "MedicinalProduct",
"display" : "Medicinal Product"
}
]
},
"domain" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-domain",
"code" : "Human",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "active"
}
]
},
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"name" : [
{
"productName" : "Lonquex 6 mg solution for injection in pre-filled syringe",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000001",
"display" : "Full name"
}
]
},
"part" : [
{
"part" : "nan",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000002",
"display" : "Invented name part"
}
]
}
},
{
"part" : "nan",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000003",
"display" : "Scientific name part"
}
]
}
},
{
"part" : "nan",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000004",
"display" : "Strength part"
}
]
}
},
{
"part" : "nan",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/lists/220000000000",
"code" : "220000000005",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "EU",
"display" : "EU"
}
]
},
"jurisdiction" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "EU",
"display" : "EU"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "en",
"display" : "en"
}
]
}
}
]
}
]
}
}
]
}
IG © 2021+ Gravitate Health Project. Package hl7.eu.fhir.ghepi#0.1.0 based on FHIR 5.0.0. Generated 2024-10-14
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
